Cargando…

ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Notice to Readers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545431/ https://www.ncbi.nlm.nih.gov/pubmed/37768876 http://dx.doi.org/10.15585/mmwr.mm7239a5

Ejemplares similares

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Tomczyk, Sara, et al.
Publicado: (2014)

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Kobayashi, Miwako, et al.
Publicado: (2022)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Bennett, Nancy M., et al.
Publicado: (2013)

Correction and Republication: Deaths and Years of Potential Life Lost From Excessive Alcohol Use — United States, 2011–2015
Publicado: (2020)

NNDSS Tables Have Updated ‘N’ Indicators for 2011–2013
Publicado: (2013)

Correction and Republication: Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic — United States, March–April 2021
Publicado: (2021)

Notice to Readers: Forthcoming Correction and Republication of the Report “Deaths and Years of Potential Life Lost From Excessive Alcohol Use — United States, 2011–2015”
Publicado: (2020)

Updated ‘N’ Indicators for the National Notifiable Diseases Surveillance System for 2014–2015
Publicado: (2015)

Correction and Republication: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
Publicado: (2023)

Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States
por: Senders, Shelly, et al.
Publicado: (2021)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
por: Gourzoulidis, George, et al.
Publicado: (2023)

Correction and Republication: New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
Publicado: (2021)

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Kobayashi, Miwako, et al.
Publicado: (2022)

1236. Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Healthy Infants in the United States
por: Senders, Shelly, et al.
Publicado: (2020)

647 Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States
por: Kim, Lindsay, et al.
Publicado: (2014)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Matanock, Almea, et al.
Publicado: (2019)

Disparities in Uptake of 13-valent Pneumococcal Conjugate Vaccine among Older Adults Following Routine Recommendation in the United States
por: McLaughlin, John, et al.
Publicado: (2017)

MMWR publications during the lapse in government funding
Publicado: (2013)

Notifiable Disease and Mortality Tables for Weeks 39–41 Now Online
Publicado: (2013)

Final 2013 Reports of Nationally Notifiable Infectious Diseases
Publicado: (2014)

Changes in the Presentation of Infectious Disease Data in the National Notifiable Diseases Surveillance System — January 2015
Publicado: (2015)

Enhanced Availability of Data for Nationally Notifiable Diseases
Publicado: (2014)

Final 2012 Reports of Nationally Notifiable Infectious Diseases
Publicado: (2013)

Notice to Readers: MMWR Weekly Launches Online Manuscript Submission System
Publicado: (2017)

Notice to Readers: New Web Location for Weekly and Annual NNDSS Data
Publicado: (2018)

Notice to Readers: Online Manuscript Submission System Now Available for MMWR Serial Publications
Publicado: (2018)

Notice to Readers: Ongoing Analysis of Suicide Rates Data by Occupational Group from Results Reported in MMWR
Publicado: (2018)

Notice to Readers: Special Podcast: “Defining Moments in MMWR History — E. coli O157:H7”
Publicado: (2017)

Notice to Readers: MMWR Rural Health Series
Publicado: (2017)

Notice to Readers: New Web Location for Annual and Weekly NNDSS Data
Publicado: (2017)

New Instructions for Authors of Reports Published in MMWR Weekly
Publicado: (2014)

MMWR Express App for iPhone and iPad Now Available
Publicado: (2014)

Discontinuation of Routine Distribution of Printed Copies of MMWR Weekly
Publicado: (2014)

Notice to Readers: New Web Location for Weekly and Annual NNDSS Data
Publicado: (2017)

Notice to Readers: Change in MMWR Announcements
Publicado: (2017)

Notice to Readers: Change in Continuing Education Activities for MMWR Weekly
Publicado: (2018)

1738. Cost-Effectiveness Analysis of Infant Pneumococcal Vaccination with the 20-Valent Pneumococcal Conjugate in the US
por: Rozenbaum, Mark, et al.
Publicado: (2023)

Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Liang, Jennifer L., et al.
Publicado: (2018)

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
por: Esposito, Susanna, et al.
Publicado: (2015)

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fi14h1q7nc895fi4prc7ttvlin